SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

Share Price is delayed by 15 minutes
Get Live Data
17.50    0.00 (0.00%)
Bid:
17.00
Ask:
18.00
Spread: 1.00 (5.882%)
Market Cap: £15.85m
TMG Live PriceLast checked at - London Stock Exchange

Intraday The Mission Group Share Chart

COVID-19 UPDATE

27 Mar 2020 17:22

RNS Number : 9435H
Mission Group PLC (The)
27 March 2020
Β 

Β 

Β 

Β 

Β 

Β 

THE MISSION GROUP plc

("MISSION", "THE GROUP")

Β 

COVID-19 UPDATE

Β 

MISSION (AIM:TMG), the alternative Group for ambitious brands, today provides an update regarding the impact of the COVID-19 outbreak on its business.

Β 

2020 began well for MISSION and whilst we have been delighted with the early progress we have made against our plans, the Covid-19 pandemic has resulted in an unprecedented global trading environment to which few businesses are immune.

Β 

The health and well-being of our teams is our priority and we have taken decisive steps to protect them, in-line with the Government guidance. The majority of our staff are used to working remotely therefore causing minimum disruption for our Client service and day to day operations.

Β 

In the short-term, the Board recognises that the developing impact of COVID-19 on global economies will result in some inevitable disruption to Client demand as companies look to reduce costs in these unprecedented times.

Β 

Given the fast-evolving circumstances it is impossible to predict the impact on the Group's performance in the current financial year ended 31 December 2020. It is however clear that the impact will be material and as such the Group is not providing guidance at the current time.

Β 

The Group is well financed, having recently increased our committed banking facilities to Β£20m and we have taken several measures to conserve cash in the short-term. These include careful management of central costs and the reduction of capital expenditure. Additionally, the Board has placed the final dividend for the last financial year (FY December 2019) due for payment in July 2020 under review. All Board members have also voluntarily reduced their salaries for the current financial year. The Group is also reviewing the latest guidance from the UK Government regarding its support for UK businesses through the current crisis and the Group anticipates that its cash flows will benefit from some of these measures.

Β 

Whilst the impact of Covid-19 on the global economy is unprecedented, MISSION has a strong balance sheet and a resilient business model servicing a broad range of Clients operating across numerous sectors and geographies. As such, the Board is confident that MISSION is well placed to continue to serve our Clients' needs and benefit from future opportunities when normal conditions return.

Β 

The Group will announce its Annual Results for the year ended 31 December 2019 on 1 April 2020 as previously confirmed and there remains no change to the guidance previously given for these results.

Β 

THE MISSION GROUP PLC

James Clifton, Chief Executive

Peter Fitzwilliam, Chief Financial Officer

Tel: 020 7462 1415

SHORE CAPITAL (Nomad and Broker)

Mark Percy / James Thomas/ Sarah Mather

Β Tel: 020 7408 4090

Β 

HOUSTON (Financial PR and Investor Relations)

Kate Hoare / Laura Stewart

Tel: 0203 760 7668

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
UPDKKOBBOBKDKNB
Date   Source Headline
19th Sep 20137:00 amRNSInterim results for the six months to 30 June 2013
30th Aug 20137:00 amRNSNotice of Interim Results
19th Jul 20137:00 amRNSDirector Exercise of Options & EBT dealing
17th Jul 20137:00 amRNSDirector Dealing
16th Jul 20137:00 amRNSDirectors' Exercise of Options
12th Jul 20137:00 amRNSDirector/PDMR Shareholding
11th Jul 20134:11 pmRNSAnnual LTIP Awards and Vesting; EBT Share Dealings
11th Jul 20137:00 amRNSDirector/PDMR Shareholding
10th Jul 20137:00 amRNSTrading Update
17th Jun 201312:30 pmRNSResult of AGM
12th Apr 20134:45 pmRNSDirector/PDMR Shareholding
11th Apr 20134:55 pmRNSDirector Dealing
10th Apr 20137:00 amRNSDirector Shareholding
3rd Apr 20137:00 amRNSDirector/PDMR Shareholding
28th Mar 20137:02 amRNSDirectors' Dealing
27th Mar 20134:10 pmRNSRegistered Office & Availability of Annual Report
25th Mar 20137:00 amRNSFinal Results
22nd Mar 20138:36 amRNSReplacement Notice of Results
22nd Mar 20137:00 amRNSNotice of Results
6th Mar 20137:00 amRNSDirectorate Change
1st Mar 20137:00 amRNSDirectorate Change
28th Jan 20137:00 amRNSTrading Update
25th Jan 20137:00 amRNSNew Client win and further expansion
9th Nov 20127:00 amRNSDirector/PDMR Shareholding
5th Nov 20127:00 amRNSDirector/PDMR Shareholding
19th Oct 201211:44 amRNSHolding(s) in Company
16th Oct 20122:59 pmRNSHolding(s) in Company
12th Oct 20127:00 amRNSAcquisition, Placing and Board Appointment
24th Sep 20127:00 amRNSAcquisition of Addiction Worldwide
19th Sep 20128:19 amRNSHalf Yearly Report
14th Sep 20123:14 pmRNSNotice of Half Year Results
20th Jul 20127:00 amRNSIssue of LTIP Awards
18th Jul 20127:01 amRNSPre Close Trading Update
18th Jul 20127:00 amRNSChange of Adviser
18th Jun 20121:03 pmRNSResult of AGM
18th Jun 201212:00 pmRNSDirectorate Change
31st May 20121:30 pmRNSContract Award
14th May 20124:04 pmRNSDirector/PDMR Shareholding
8th May 20122:01 pmRNSDirector/PDMR Shareholding
4th May 20122:47 pmRNSDirector/PDMR Shareholding
1st May 20127:00 amRNSDirector/PDMR Shareholding
16th Apr 20123:34 pmRNSHolding(s) in Company
27th Mar 20127:00 amRNSFinal Results
22nd Mar 20127:00 amRNSNotice of Results
26th Jan 20127:00 amRNSTrading Statement
24th Jan 20127:00 amRNSDirector/PDMR Shareholding
6th Jan 20129:13 amRNSDirector/PDMR Shareholding
21st Nov 20114:17 pmRNSDirector/PDMR Shareholding
3rd Oct 20112:44 pmRNSDirector/PDMR Shareholding
30th Sep 20117:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.